First Affiliated Hospital of Xi'an Jiaotong University
3 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a conceptual framework paper proposing mechanistic hypotheses about hepatic disease as a modifier of immunotherapy efficacy in colorectal cancer, without new primary data or definitive evidence.
Early-stage preclinical work demonstrating proof-of-concept in cell culture and mouse models; no clinical efficacy data, human trials, or comparison to standard cervical cancer therapy reported.
A large, rigorous secondary analysis of established GBD data with robust methods (joinpoint regression, decomposition, age-period-cohort modelling) confirming that thermal injury burden in North Africa and the Middle East declined age-standardized over 1990–2023, consistent with global injury control trends.